H

Harbour Antibodies

10 employees

Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Unlimited Access
Antibodies
Murine antibody humanization
Pharmaceutical
Transgenic Mouse
H2L2
Single Program Access
Therapeutics
Mouse antibody platform
Antibody Discovery Platform
Soluble antigen specific VH domains
Heavy Chain Only Antibody
Limited Access
HCAb

Date founded

2006

Funding rounds raised

Total raised

$3.3M

from 1 investors over 1 rounds

H

Harbour Antibodies raised $3.3M on July 24, 2013

Investors: Atlas Venture

FAQ